NCT03878849
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03878849
Title Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Allarity Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
OU Health Stephenson Cancer RECRUITING Oklahoma City Oklahoma 73104 United States Details
Swedish Center for Research and Innovation RECRUITING Seattle Washington 98122 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field